Last updated on March 2019

A Study of ONO-7475 in Patients With Acute Leukemias

Brief description of study

This study will determine the safety and maximum tolerated dose of ONO-7475 in patients with relapsed or refractory acute leukemia and evaluate the efficacy of ONO-7475 in patients with newly diagnosed AML

Clinical Study Identifier: NCT03176277

Find a site near you

Start Over